Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Valentini

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Molecular Biosciences|October 30, 2023
Unlocking the potential of Tregs: innovations in CAR technologyChristopher J Requejo Cier, Nicolas Valentini, Caroline Lamarche
Clinical and Experimental Immunology|May 9, 2023
Regulatory T-cell dysfunction and its implication for cell therapyNicolas Valentini, Christopher J Requejo Cier, Caroline Lamarche
Immunology and Cell Biology|May 4, 2025
Highlights of 2024: Tregs immunometabolism and how to counter inflammatory nichesNicolas Valentini, Christopher J Requejo Cier, Caroline Lamarche
Frontiers in Immunology|May 4, 2026
Engineering human Tregs to resist tacrolimus via FKBP12 gene editingChristopher J Requejo Cier, Nicolas Valentini, Gabrielle Boudreau, et al.
Kidney360|December 14, 2022
Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis PatientsNicolas Valentini, Lorie Marchitto, Maxime Raymond, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Molecular Biosciences|October 30, 2023
Unlocking the potential of Tregs: innovations in CAR technologyChristopher J Requejo Cier, Nicolas Valentini, Caroline Lamarche
Clinical and Experimental Immunology|May 9, 2023
Regulatory T-cell dysfunction and its implication for cell therapyNicolas Valentini, Christopher J Requejo Cier, Caroline Lamarche
Immunology and Cell Biology|May 4, 2025
Highlights of 2024: Tregs immunometabolism and how to counter inflammatory nichesNicolas Valentini, Christopher J Requejo Cier, Caroline Lamarche
Frontiers in Immunology|May 4, 2026
Engineering human Tregs to resist tacrolimus via FKBP12 gene editingChristopher J Requejo Cier, Nicolas Valentini, Gabrielle Boudreau, et al.
Kidney360|December 14, 2022
Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis PatientsNicolas Valentini, Lorie Marchitto, Maxime Raymond, et al.
Pageof 1